Altasciences Featured Audio

  1. Issue 7: Understanding The Intrinsic And Extrinsic Factors That Alter Drug Exposure And Toxicity 2/2/2023

    Discuss effective pharmaceutical therapies, specifically, understanding the intrinsic and extrinsic factors that alter exposure to limit adverse effects and maximize treatment response.

  2. Issue 6: Hybrid Medicines And 505(b)(2) NDA Approval Pathways 2/2/2023

    Learn why hybrid medicines require re-approval for market authorization, partly based on data from the original reference medicine, and partly on data from new clinical trials on the modified version.

  3. Issue 5: The Global Challenge Of Metabolic Disorders 2/2/2023

    Metabolic disorders can take many forms, with obesity and diabetes being the most common. Once considered a high-income country problem, learn why obesity is now on the rise even in low- and middle-income countries.

  4. Issue 4: Key Considerations for Biosimilar Clinical Pharmacology Studies 2/2/2023

    In this issue, explore key considerations for biosimilar clinical pharmacology studies.

  5. Issue 3: Human Abuse Potential Studies 2/2/2023

    In this issue, dive into HAP studies, and the importance of an exert drug development solution partner in human abuse potential.

  6. Issue 2: Revolutionizing Traditional Medicine With Cannabis-Based Medicinal Products 2/1/2023

    When a sponsor wanted to conduct a first-in-human test on a cannabis extract being studied for use in breakthrough cancer pain, discover the collaboration on the ideal development plan.

  7. Issue 1: Studying The Effects Of Drugs On Driving 2/1/2023

    With more than 6,800 FDA-approved drugs, it is crucial to put in place a systematic effort to identify the drugs that increase the risk of motor vehicle accidents.